Timothy M. Miller

18.6k citations

185 papers · 12.3k indexed · 9 hit papers · h-index 48

Molecular Biology top 1%
Neurology top 0.1%
Physiology top 0.5%
Genetics top 0.2%
Cellular and Molecular Neuroscience top 0.5%

Co-authors: Don W. Cleveland Lucie Bruijn Sarah L. DeVos Eugene M. Johnson Kathleen M. Schoch Marc I. Diamond Lewis J. Rothberg Ananth Dodabalapur
Topics: Amyotrophic Lateral Sclerosis Research (65 papers)Neurogenetic and Muscular Disorders Research (51 papers)Superconducting and THz Device Technology (17 papers)
Cited by: Neurology Genetics
Journals: Science Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Canada United Kingdom

In The Last Decade

Timothy M. Miller

175 papers receiving 12.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS

2004 1.2k citations Timothy M. Miller, Don W. Cleveland et al. profile →
Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies

2014 720 citations David W. Sanders, Sarah K. Kaufman et al. Neuron profile →
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds

2013 649 citations Brandon B. Holmes, Sarah L. DeVos et al. Proceedings of the National Academy of Sciences profile →
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia

2013 577 citations Timothy M. Miller, Matthew B. Harms et al. Proceedings of the National Academy of Sciences profile →
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

2013 492 citations Timothy M. Miller, Alan Pestronk et al. profile →
C9orf72 is required for proper macrophage and microglial function in mice

2016 400 citations Jacqueline G. O’Rourke, Laurent Bogdanik et al. Science profile →
Tau Kinetics in Neurons and the Human Central Nervous System

2018 397 citations Bruce W. Patterson, Jennifer Jockel‐Balsarotti et al. Neuron profile →
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy

2017 362 citations Sarah L. DeVos, Kathleen M. Schoch et al. profile →
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD

2024 52 citations Katherine E. Irwin, Kerstin E. Braunstein et al. Nature Medicine profile →

Peers

Countries citing papers authored by Timothy M. Miller

Since Specialization

Citations

This map shows the geographic impact of Timothy M. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy M. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy M. Miller more than expected).

Fields of papers citing papers by Timothy M. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy M. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy M. Miller. The network helps show where Timothy M. Miller may publish in the future.

Co-authorship network of co-authors of Timothy M. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy M. Miller. A scholar is included among the top collaborators of Timothy M. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy M. Miller. Timothy M. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives 2024 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Ik Jae Lee,(unknown),Joanne Wuu,Elizabeth A. Harrington,James D. Berry,Timothy M. Miller,Matthew B. Harms,Michael Benatar,Neil A. Shneider	0
2	Access for ALL in ALS: A large‐scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis 2024 ·Muscle & Nerve ·James D. Berry,Sabrina Paganoni,Matthew Harms,Neil A. Shneider,Jinsy Andrews,Timothy M. Miller,Suma Babu,(unknown),Brent T. Harris,Frank A. Provenzano,Hemali Phatnani,Jeremy M. Shefner,(unknown),(unknown),Amy Y. Tsou,Praveena Mohan,(unknown),Robert Bowser	1
3	A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTDbreakdown → 2024 ·Nature Medicine ·Katherine E. Irwin,(unknown),Kerstin E. Braunstein,Irika R. Sinha,(unknown),(unknown),Koping Chang,Juan C. Troncoso,Abhay Moghekar,Esther S. Oh,Denitza Raitcheva,(unknown),Timothy M. Miller,James D. Berry,Bryan J. Traynor,Jonathan P. Ling,Philip C. Wong	52
4	Two-Stage Fine-Tuning for Improved Bias and Variance for Large Pretrained Language Models 2023 ·Lijing Wang,(unknown),Timothy M. Miller,Steven Bethard,Guergana Savova	4
5	Targeted ASO-mediated Atp1a2 knockdown in astrocytes reduces SOD1 aggregation and accelerates disease onset in mutant SOD1 mice 2023 ·PLoS ONE ·(unknown),Kathleen M. Schoch,(unknown),(unknown),Hao Chen,Sarah E. Smith,Anna Oldenborg,Timothy M. Miller,Celeste M. Karch,(unknown)	3
6	Lumbar punctures are safe in patients with ALS and have a risk profile similar to that in the non‐ALS population 2023 ·Muscle & Nerve ·Collin J. Kreple,(unknown),(unknown),Robert C. Bucelli,Timothy M. Miller	1
7	TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma 2023 ·Science Advances ·Rui Sun,Rowland H. Han,(unknown),Saad M. Khan,G. Travis Tabor,Yun Chen,Jinchao Hou,Haowu Jiang,Kathleen M. Schoch,Diane D. Mao,Ryan T. Cleary,Alicia Yang,Qin Liu,Jingqin Luo,Allegra A. Petti,Timothy M. Miller,Jason D. Ulrich,David M. Holtzman,Albert H. Kim	62
8	Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse Model 2023 ·Annals of Neurology ·Collin J. Kreple,Susan Searles Nielsen,Kathleen M. Schoch,Tao Shen,Mark Shabsovich,Yizhe Song,Brad A. Racette,Timothy M. Miller	4
9	Protein kinetics of superoxide dismutase‐1 in familial and sporadic amyotrophic lateral sclerosis 2023 ·Annals of Clinical and Translational Neurology ·Cindy V. Ly,(unknown),Wade Self,James Bollinger,Jennifer Jockel‐Balsarotti,(unknown),Peggy Allred,(unknown),Michael W. Doyle,(unknown),(unknown),(unknown),(unknown),Katherine L. Nicholson,Robert C. Bucelli,Bruce W. Patterson,Randall J. Bateman,Timothy M. Miller	7
10	MiToS and King’s staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial 2022 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·(unknown),Lisa Meng,Stacy A. Rudnicki,(unknown),(unknown),Andrew A. Wolff,Adriano Chiò,Jinsy Andrews,Angela Genge,Carlayne E. Jackson,Noah Lechtzin,Timothy M. Miller,Jeremy M. Shefner	3
11	Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD 2022 ·Nature Communications ·Gopinath Krishnan,Denitza Raitcheva,Daniel A. Bartlett,Mercedes Prudencio,Diane McKenna‐Yasek,Catherine Douthwright,Björn Oskarsson,Shafeeq Ladha,Oliver D. King,Sami J. Barmada,Timothy M. Miller,Robert Bowser,Jonathan K. Watts,Leonard Petrucelli,Robert H. Brown,Mark W. Kankel,Fen‐Biao Gao	31
12	TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy 2021 ·Science Advances ·Carolina Alquézar,Kathleen M. Schoch,Ethan G. Geier,Eliana Marisa Ramos,Aurora Scrivo,Kathy H. Li,Andrea R. Argouarch,Elisabeth E. Mlynarski,Beth A. Dombroski,Michael DeTure,Dennis W. Dickson,Jennifer S. Yokoyama,Ana María Cuervo,Alma L. Burlingame,Gerard D. Schellenberg,Timothy M. Miller,Bruce L. Miller,Aimee W. Kao	26
13	A viral toolkit for recording transcription factor–DNA interactions in live mouse tissues 2020 ·Proceedings of the National Academy of Sciences ·Alexander J. Cammack,(unknown),Jiayang Chen,Michael J. Vasek,Mark Shabsovich,Katherine B. McCullough,(unknown),(unknown),Susan E. Maloney,June He,Xuhua Chen,(unknown),Michael Wilkinson,Timothy M. Miller,Robi D. Mitra,Joseph D. Dougherty	13
14	Extracting Relations between Radiotherapy Treatment Details 2020 ·Danielle S. Bitterman,Timothy M. Miller,David J. Harris,Chen Lin,Sean Finan,Jeremy L. Warner,Raymond H. Mak,Guergana Savova	5
15	C9orf72 is required for proper macrophage and microglial function in micebreakdown → 2016 ·Science ·Jacqueline G. O’Rourke,Laurent Bogdanik,Alberto Yáñez,Deepti Lall,Andrea J. Wolf,A.K.M. Ghulam Muhammad,Ritchie Ho,Sharon Carmona,Jean‐Philippe Vit,Jonah E. Zarrow,(unknown),Shaughn Bell,Matthew B. Harms,Timothy M. Miller,Charles A. Dangler,David M. Underhill,Helen S. Goodridge,Cathleen Lutz,Robert H. Baloh	400
16	Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo 2016 ·Neuron ·Sarah K. Kaufman,David W. Sanders,Talitha L. Thomas,Allison Ruchinskas,Jaime Vaquer‐Alicea,Apurwa M Sharma,Timothy M. Miller,Marc I. Diamond	318
17	The TREM2 Variant p.R47H is a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis (I5-2.002) 2014 ·Neurology ·Matthew Harms,Janet Cady,Erica Koval,Bruno A. Benítez,Craig M. Zaidman,Jennifer Jockel‐Balsarotti,Peggy Allred,Robert H. Baloh,John Ravits,Ericka Simpson,Stanley H. Appel,Alan Pestronk,Alison Goate,Timothy M. Miller,Carlos Cruchaga	1
18	Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seedsbreakdown → 2013 ·Proceedings of the National Academy of Sciences ·Brandon B. Holmes,Sarah L. DeVos,Najla Kfoury,Mei Li,(unknown),Kiran Yanamandra,Mohand Ouidir Ouidja,Frances M. Brodsky,Jayne Marasa,Devika P. Bagchi,Paul T. Kotzbauer,Timothy M. Miller,Dulce Papy-García,Marc I. Diamond	649
19	Antisense Reduction of Tau in Adult Mice Protects against Seizures 2013 ·Journal of Neuroscience ·Sarah L. DeVos,(unknown),Guojun Chen,(unknown),Kaoru Yamada,Floy R. Stewart,Dorothy R. Schuler,Susan E. Maloney,David F. Wozniak,Frank Rigo,C. Frank Bennett,John R. Cirrito,David M. Holtzman,Timothy M. Miller	250
20	ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import 2010 ·Proceedings of the National Academy of Sciences ·Quan Li,Christine Vande Velde,Adrian Israelson,Jing Xie,Aaron O. Bailey,(unknown),(unknown),(unknown),(unknown),John R. Yates,Roderick Capaldi,Don W. Cleveland,Timothy M. Miller	141

About Timothy M. Miller

Timothy M. Miller is a scholar working on Genetics, Neurology and Neurology, having authored 185 papers that have together received 12.3k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (65 papers), Neurogenetic and Muscular Disorders Research (51 papers) and Superconducting and THz Device Technology (17 papers). The work is most often cited by research in Neurology (4.7k citations), Neurology (2.1k citations) and Genetics (2.6k citations). Timothy M. Miller has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Don W. Cleveland, Lucie Bruijn, Sarah L. DeVos, Eugene M. Johnson, Kathleen M. Schoch, Marc I. Diamond, Lewis J. Rothberg, Ananth Dodabalapur, Douglas J. Creedon and Christine Vande Velde. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact